CVS Health vs Moderna

CVS Health (CVS), health care, and Moderna (MRNA), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

CVS Health is worth $111B on the stock market and Moderna $83.9B: CVS Health is valued at 32% more. CVS Health's operating margin in its latest fiscal year was 1.16% and Moderna's -158%. Over the past year CVS Health's share price has moved +13.7% and Moderna's +764%.

Key facts

CVS Health market value
$111B
Moderna market value
$83.9B
CVS Health P/E
10.1
CVS Health revenue
$402.1BFY to 2025-12-31
Moderna revenue
$1.9BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

CVS Health vs Moderna: every measure side by side
Measure CVS Health Moderna
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$111Bhigher$83.9Blower
Revenue$402.1Bhigher$1.9Blower
Earnings$1.8Bhigher-$2.8Blower
Employees219,000higher4,700lower
Total assets$253.5Bhigher$12.3Blower
Valuation
P/E10.1—
P/S0.3lower43.2higher
P/B1.4lower12.3higher
Dividend yield3.00%higher0.00%lower
Profitability
Operating margin1.16%higher-158%lower
Balance sheet
Net assets$75.2Bhigher$8.7Blower
Total liabilities$178.2Bhigher$3.7Blower
Total debt$64.6Bhigher$590Mlower
Cash on hand$8.5Bhigher$2.6Blower
Price change
Today-2.09%higher-3.65%lower
1 year+13.7%lower+764%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio. Who owns CVS · Who owns MRNA

Further comparisons

Learn

Questions and answers

Which is bigger, CVS Health or Moderna?

By market value, CVS Health is the larger: $111B against $83.9B for Moderna. By revenue in its latest fiscal year, CVS Health is the larger: $402.1B against $1.9B for Moderna.

Which has the higher operating margin?

CVS Health: 1.16%, against -158% for Moderna. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

CVS Health: 3.00%, against 0.00% for Moderna. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

CVS Health: $64.6B, against $590M for Moderna. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both CVS Health and Moderna?

None of the tracked superinvestors holds both in their latest 13F filing. 22 hold CVS Health and 2 hold Moderna.

Cite this page

Funkfolio, “CVS Health vs Moderna”, data as of 17 November 2026. https://funkfolio.com/compare/cvs-vs-mrna

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.